000 01727cas  2200397zi 4500
0019.893870
003CaOODSP
00520220624085523
006m     o  d f      
007cr cn|||||||||
008201120c20209999oncqr p o    f0###a0eng|d
022 |a2563-6723
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH162-5E-PDF
1101 |aCanada. |bBiologic and Radiopharmaceutical Drugs Directorate, |eauthor, |eissuing body.
222 0|aDrug submission performance quarterly report |b(Canada. Biologic and Radiopharmaceutical Drugs Directorate)
24510|aDrug submission performance quarterly report / |cBiologic and Radiopharmaceutical Drugs Directorate.
24617|aBRDD quarterly drug submission performance report
264 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c2020-
310 |aQuarterly
336 |atext|2rdacontent
337 |acomputer|2rdamedia
338 |aonline resource|2rdacarrier
3621 |aBegan with: January 2020 to September 2020.
500 |aIssued also in French under title: Rapport trimestriel du rendement des présentations de drogue.
516 |aElectronic serial in PDF format.
650 0|aPharmaceutical policy|zCanada|vPeriodicals.
650 0|aDrugs|xLaw and legislation|zCanada|vPeriodicals.
650 0|aDrugs|xTesting|xStandards|vPeriodicals.
650 0|aDrugs|xTesting|xGovernment policy|zCanada|vPeriodicals.
651 6|aCanada.
655 7|aPeriodicals|2lcgft
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tRapport trimestriel du rendement des présentations de drogue / |w(CaOODSP)9.893873
78000|tDrug submission performance quarterly report ... |w(CaOODSP)9.507530